Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-fluoro-11 Beta,16 Alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone, 21-(3,3-dimethylbutyrate)
2. Aristospan
1. 5611-51-8
2. Aristospan
3. Lederspan
4. Tatba
5. Cl 34433
6. Tiamcinoloni Hexacetonidum [inn]
7. Chebi:9670
8. I7gt1u99y9
9. [2-[(1s,2s,4r,8s,9s,11s,12r,13s)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 3,3-dimethylbutanoate
10. Aristospan (tn)
11. Pregna-1,4-diene-3,20-dione,21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11b,16a)-
12. Triamcinolone Esacetonide
13. Tiamcinoloni Hexacetonidum
14. Triamcinoloni Hexacetonidum
15. Hexacetonide De Triamcinolone
16. Hexacetonido De Triancinolona
17. Unii-i7gt1u99y9
18. Triamcinolone Esacetonide [dcit]
19. Ncgc00182544-01
20. (11?,16?)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
21. Einecs 227-031-4
22. Brn 1413888
23. Triamcinoloni Hexacetonidum [inn-latin]
24. Cl-34433
25. Hexacetonide De Triamcinolone [inn-french]
26. Triamcinolone-hexacetonide
27. Hexacetonido De Triancinolona [inn-spanish]
28. Triamcinolone Hexace-tonide
29. Schembl7543
30. Triamcinolone Hexacetonide [usan:usp:inn:ban]
31. Dsstox_cid_28560
32. Dsstox_rid_82832
33. Dsstox_gsid_48634
34. 5-19-06-00569 (beilstein Handbook Reference)
35. Triamcinolonehexacetonide
36. Chembl1200878
37. Dtxsid0048634
38. 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone 21-(3,3-dimethylbutyrate)
39. Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11.beta.,16.alpha.)-
40. Zinc4097475
41. Tox21_112979
42. Hy-u00103
43. Triamcinolone Hexacetonide (usp/inn)
44. Cs-7139
45. Triamcinolone Hexacetonide [mi]
46. Triamcinolone Hexacetonide [inn]
47. Triamcinolone Hexacetonide [usan]
48. 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione Cyclic 16,17-acetal With Acetone 21-(3,3-dimethylbutyrate)
49. Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-
50. Triamcinolone Hexacetonide [mart.]
51. Triamcinolone Hexacetonide [vandf]
52. Cas-5611-51-8
53. Triamcinolone Hexacetonide [usp-rs]
54. Triamcinolone Hexacetonide [who-dd]
55. C08185
56. D00985
57. Triamcinolone Hexacetonide [orange Book]
58. Triamcinolone Hexacetonide [ep Monograph]
59. Triamcinolone Hexacetonide [usp Impurity]
60. Triamcinolone Hexacetonide [usp Monograph]
61. Q1593246
62. (11beta,16alpha)-21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione
63. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, Cyclic 16,17-acetal With Acetone, 21-(3,3-dimethylbutyrate)
64. Pregna-1,4-diene-3,20-dione,21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11b,16a)-
Molecular Weight | 532.6 g/mol |
---|---|
Molecular Formula | C30H41FO7 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 532.28363180 g/mol |
Monoisotopic Mass | 532.28363180 g/mol |
Topological Polar Surface Area | 99.1 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 1130 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17758
Submission : 2004-10-15
Status : Active
Type : II
Certificate Number : CEP 2018-282 - Rev 03
Issue Date : 2024-07-25
Type : Chemical
Substance Number : 867
Status : Valid
NDC Package Code : 46439-8728
Start Marketing Date : 2008-05-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37346
Submission : 2022-08-04
Status : Active
Type : II
Certificate Number : R0-CEP 2021-078 - Rev 00
Issue Date : 2022-03-28
Type : Chemical
Substance Number : 867
Status : Valid
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8329
Submission : 1989-12-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6958
Submission : 1987-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9847
Submission : 1992-08-28
Status : Inactive
Type : II
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
About the Company : A research-based international pharmaceutical company, Coral Drugs has more than 27 years of expertise in manufacturing a wide variety of high-quality and affordable active pharmac...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
About the Company : Avik Pharmaceutical was a dream project started with an aim to manufacture lifesaving critical API's in India. Guided by the vision of Mr Anant Thakore, Avik has been the pioneer t...
About the Company : Chemos® is one of the leading manufacturers of ready-to-use solutions in the laboratory and the chemical industry. We produce reagents and standards for chemical analysis in the l...
About the Company : Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We...
About the Company : J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Valu...
About the Company : Molcan Corporation is involved in design, research, development and production of fine chemicals, API related compounds, impurities, intermediates, metabolites, internal standards ...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Triamcinolone Hexacetonide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triamcinolone Hexacetonide, including repackagers and relabelers. The FDA regulates Triamcinolone Hexacetonide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triamcinolone Hexacetonide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Triamcinolone Hexacetonide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Triamcinolone Hexacetonide supplier is an individual or a company that provides Triamcinolone Hexacetonide active pharmaceutical ingredient (API) or Triamcinolone Hexacetonide finished formulations upon request. The Triamcinolone Hexacetonide suppliers may include Triamcinolone Hexacetonide API manufacturers, exporters, distributors and traders.
click here to find a list of Triamcinolone Hexacetonide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Triamcinolone Hexacetonide DMF (Drug Master File) is a document detailing the whole manufacturing process of Triamcinolone Hexacetonide active pharmaceutical ingredient (API) in detail. Different forms of Triamcinolone Hexacetonide DMFs exist exist since differing nations have different regulations, such as Triamcinolone Hexacetonide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Triamcinolone Hexacetonide DMF submitted to regulatory agencies in the US is known as a USDMF. Triamcinolone Hexacetonide USDMF includes data on Triamcinolone Hexacetonide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triamcinolone Hexacetonide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Triamcinolone Hexacetonide suppliers with USDMF on PharmaCompass.
A Triamcinolone Hexacetonide CEP of the European Pharmacopoeia monograph is often referred to as a Triamcinolone Hexacetonide Certificate of Suitability (COS). The purpose of a Triamcinolone Hexacetonide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Triamcinolone Hexacetonide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Triamcinolone Hexacetonide to their clients by showing that a Triamcinolone Hexacetonide CEP has been issued for it. The manufacturer submits a Triamcinolone Hexacetonide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Triamcinolone Hexacetonide CEP holder for the record. Additionally, the data presented in the Triamcinolone Hexacetonide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Triamcinolone Hexacetonide DMF.
A Triamcinolone Hexacetonide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Triamcinolone Hexacetonide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Triamcinolone Hexacetonide suppliers with CEP (COS) on PharmaCompass.
A Triamcinolone Hexacetonide written confirmation (Triamcinolone Hexacetonide WC) is an official document issued by a regulatory agency to a Triamcinolone Hexacetonide manufacturer, verifying that the manufacturing facility of a Triamcinolone Hexacetonide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Triamcinolone Hexacetonide APIs or Triamcinolone Hexacetonide finished pharmaceutical products to another nation, regulatory agencies frequently require a Triamcinolone Hexacetonide WC (written confirmation) as part of the regulatory process.
click here to find a list of Triamcinolone Hexacetonide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Triamcinolone Hexacetonide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Triamcinolone Hexacetonide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Triamcinolone Hexacetonide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Triamcinolone Hexacetonide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Triamcinolone Hexacetonide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Triamcinolone Hexacetonide suppliers with NDC on PharmaCompass.
Triamcinolone Hexacetonide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Triamcinolone Hexacetonide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triamcinolone Hexacetonide GMP manufacturer or Triamcinolone Hexacetonide GMP API supplier for your needs.
A Triamcinolone Hexacetonide CoA (Certificate of Analysis) is a formal document that attests to Triamcinolone Hexacetonide's compliance with Triamcinolone Hexacetonide specifications and serves as a tool for batch-level quality control.
Triamcinolone Hexacetonide CoA mostly includes findings from lab analyses of a specific batch. For each Triamcinolone Hexacetonide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Triamcinolone Hexacetonide may be tested according to a variety of international standards, such as European Pharmacopoeia (Triamcinolone Hexacetonide EP), Triamcinolone Hexacetonide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triamcinolone Hexacetonide USP).
LOOKING FOR A SUPPLIER?